192 related articles for article (PubMed ID: 31674306)
21. IPVS statement on "Temporary HPV vaccine shortage: Implications globally to achieve equity".
Garland SM; Stanley MA; Giuliano AR; Moscicki AB; Kaufmann A; Bhatla N; Woo YL;
Papillomavirus Res; 2020 Jun; 9():100195. PubMed ID: 32205196
[No Abstract] [Full Text] [Related]
22. Two new vaccines: Gardasil and Rotateq.
Van Gilder D
S D Med; 2007 Jan; 60(1):13-4. PubMed ID: 17319292
[No Abstract] [Full Text] [Related]
23. Human papillomavirus vaccines: an update for gynecologists.
Ault KA
Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145
[TBL] [Abstract][Full Text] [Related]
24. Prophylactic and therapeutic human papillomavirus vaccine: a breakthrough for women health.
Yousuf S; Syed S
J Pak Med Assoc; 2009 May; 59(5):310-4. PubMed ID: 19438137
[TBL] [Abstract][Full Text] [Related]
25. [Implementation of HPV vaccination in Germany].
Schreckenberger C; Kaufmann AM; Schneider A
Dtsch Med Wochenschr; 2007 Oct; 132(42):2221-4. PubMed ID: 17926251
[No Abstract] [Full Text] [Related]
26. HPV vaccines: what remains to be done? Interview by Lauren Constable.
Zur Hausen H
Expert Rev Vaccines; 2011 Nov; 10(11):1505-7. PubMed ID: 22043949
[No Abstract] [Full Text] [Related]
27. The rationale for implementation of HPV testing in routine cervical screening in Romania.
Iancu LS; Ursu RG
Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):293-6. PubMed ID: 24340506
[No Abstract] [Full Text] [Related]
28. HPV vaccination in Southern Africa: A jab of hope in the fight against cervical cancer.
Michelow P; Firnhaber C
Cancer Cytopathol; 2016 Oct; 124(10):695-698. PubMed ID: 27182785
[No Abstract] [Full Text] [Related]
29. [Pediatricians are key physicians for the eradication of cervix cancer].
Martinón-Torres F
Med Clin (Barc); 2008 Apr; 130(12):478; author reply 478-9. PubMed ID: 18405509
[No Abstract] [Full Text] [Related]
30. Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines.
Pedersen K; Burger EA; Nygård M; Kristiansen IS; Kim JJ
Eur J Cancer; 2018 Mar; 91():68-75. PubMed ID: 29335156
[TBL] [Abstract][Full Text] [Related]
31. [Expert consensus on immunoprophylaxis of human papillomavirus-related diseases (abridged)].
Vaccine and Immunization Branch, Chinese Preventive Medicine Association
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Dec; 53(12):1218-1235. PubMed ID: 31795578
[TBL] [Abstract][Full Text] [Related]
32. Eradication of cervical cancer: the beginning of the end.
Hillemanns P
Arch Gynecol Obstet; 2014 Mar; 289(3):477-8. PubMed ID: 24402328
[No Abstract] [Full Text] [Related]
33. IPVS statement moving towards elimination of cervical cancer as a public health problem.
Garland SM; Giuliano A; Brotherton J; Moscicki AB; Stanley M; Kaufmann AM; Bhatla N; Sankaranarayanan R; Palefsky JM; de Sanjose S;
Papillomavirus Res; 2018 Jun; 5():87-88. PubMed ID: 29499389
[No Abstract] [Full Text] [Related]
34. A systematic review of literature about women's knowledge and attitudes toward human papillomavirus (HPV) vaccination.
Chan ZC; Chan TS; Ng KK; Wong ML
Public Health Nurs; 2012 Nov; 29(6):481-9. PubMed ID: 23078419
[TBL] [Abstract][Full Text] [Related]
35. Human papilloma virus vaccine for low and middle income countries: A step too soon?
Jindal HA; Kaur A; Murugan S
Hum Vaccin Immunother; 2017 Nov; 13(11):2723-2725. PubMed ID: 28846491
[TBL] [Abstract][Full Text] [Related]
36. [EUROGIN 2010: roadmap on cervical cancer prevention].
Monsonego J
Gynecol Obstet Fertil; 2011; 39(7-8):462-7. PubMed ID: 21764621
[No Abstract] [Full Text] [Related]
37. The investment case for cervical cancer elimination.
Tsu VD; Ginsburg O
Int J Gynaecol Obstet; 2017 Jul; 138 Suppl 1():69-73. PubMed ID: 28691328
[TBL] [Abstract][Full Text] [Related]
38. Anticipating full benefits from the new papillomavirus vaccines.
Griffiths PD
Rev Med Virol; 2007; 17(1):1-3. PubMed ID: 17173349
[No Abstract] [Full Text] [Related]
39. HPV-vaccination impact in Denmark: is the vaccine working?
Lynge E; Skorstengaard M; Lübker CL; Thamsborg L
Expert Rev Vaccines; 2018 Sep; 17(9):765-767. PubMed ID: 30079782
[No Abstract] [Full Text] [Related]
40. Prevention of HPV disease burden.
Lehtinen M; Nieminen P; Apter D; Paavonen J
Womens Health (Lond); 2014 Jul; 10(4):341-3. PubMed ID: 25259894
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
